Merck’s combination therapy in lung cancer fails a Phase 2 clinical trial,Merck & Co....
Merck & Co. Inc.
Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation,Moderna Inc. and Merck Inc....
Moderna earnings fall short of estimates amid steep decline in COVID vaccine sales, expects...
